This company listing is no longer active
Idogen Dirección
Dirección controles de criterios 1/4
Idogen's CEO is Christina Herder, appointed in Sep 2022, they has a tenure of less than a year. Their total yearly compensation is SEK454.00K , comprised of 66.1% salary and 33.9% bonuses, including company stock and options. They directly owns 0.06% of the company’s shares, worth SEK7.56K. The average tenure of the management team and the board of directors is 1.5 years and 2.7 years respectively.
Información clave
Christina Herder
Chief Executive Officer (CEO)
SEK 454.0k
Compensación total
| Porcentaje del salario del CEO | 66.1% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.06% |
| Permanencia media de la dirección | 1.5yrs |
| Promedio de permanencia en la Junta Directiva | 2.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -SEK 44m |
| Dec 31 2022 | SEK 454k | SEK 300k | -SEK 48m |
| Sep 30 2022 | n/a | n/a | -SEK 50m |
| Jun 30 2022 | n/a | n/a | -SEK 41m |
| Mar 31 2022 | n/a | n/a | -SEK 39m |
| Dec 31 2021 | SEK 150k | n/a | -SEK 39m |
| Sep 30 2021 | n/a | n/a | -SEK 33m |
| Jun 30 2021 | n/a | n/a | -SEK 33m |
| Mar 31 2021 | n/a | n/a | -SEK 31m |
| Dec 31 2020 | SEK 150k | n/a | -SEK 27m |
Compensación vs. Mercado: Christina's total compensation ($USD42.19K) is below average for companies of similar size in the Swedish market ($USD231.64K).
Compensación vs. Ingresos: Christina's compensation has increased whilst the company is unprofitable.
CEO
Christina Herder (62 yo)
less than a year
Permanencia
SEK 454,000
Compensación
Dr. Christina Herder, Ph D., served as Independent Director for Ziccum AB (publ) since April 28, 2022 until May 2023. She is Director at Beactica AB since 2021.She is a Director at Elicera Therapeutics AB...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Acting CEO & Director | less than a year | SEK 454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | no data | SEK 150.00k | 0.17% SEK 22.0k | |
| Chief Financial Officer | 7.2yrs | sin datos | 0.33% SEK 42.1k | |
| Chief Technology Officer | 9.5yrs | SEK 120.74k | 0.012% SEK 1.5k | |
| Chief Medical Officer | 1.5yrs | sin datos | sin datos | |
| Chief Regulatory Officer | 1.3yrs | sin datos | sin datos |
1.5yrs
Permanencia media
62yo
Promedio de edad
Equipo directivo experimentado: IDOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Acting CEO & Director | 6.2yrs | SEK 454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | 7.8yrs | SEK 150.00k | 0.17% SEK 22.0k | |
| Independent Chairman of the Board | 7.3yrs | SEK 407.00k | 0.15% SEK 18.9k | |
| Member of Scientific Advisory Board | 7.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.3yrs | sin datos | sin datos | |
| Independent Director | 3.2yrs | SEK 150.00k | 0.089% SEK 11.1k | |
| Member of Scientific Advisory Board | 2.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | less than a year | sin datos | sin datos | |
| Member of Scientific Advisory Board | less than a year | sin datos | sin datos |
2.7yrs
Permanencia media
64.5yo
Promedio de edad
Junta con experiencia: IDOGEN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.